Alligator Bioscience AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
For the six months, sales was SEK 14.55 million compared to SEK 26.96 million a year ago. Revenue was SEK 15.38 million compared to SEK 29.09 million a year ago. Net loss was SEK 111.96 million compared to SEK 126.26 million a year ago. Basic loss per share from continuing operations was SEK 0.16 compared to SEK 0.46 a year ago. Diluted loss per share from continuing operations was SEK 0.16 compared to SEK 0.46 a year ago.